SG15595G - Antimigraine alkoxypyrimidine derivatives - Google Patents

Antimigraine alkoxypyrimidine derivatives

Info

Publication number
SG15595G
SG15595G SG15595A SG15595A SG15595G SG 15595 G SG15595 G SG 15595G SG 15595 A SG15595 A SG 15595A SG 15595 A SG15595 A SG 15595A SG 15595 G SG15595 G SG 15595G
Authority
SG
Singapore
Prior art keywords
antimigraine
alkoxypyrimidine
derivatives
alkoxypyrimidine derivatives
indolylalkyl
Prior art date
Application number
SG15595A
Other languages
English (en)
Inventor
David W Smith
Frank D Yocca
Joseph P Yevich
Ronald J Mattson
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CA002043709A priority Critical patent/CA2043709C/fr
Priority to EP91110376A priority patent/EP0464558B1/fr
Priority to DK91110376.0T priority patent/DK0464558T3/da
Priority to ES91110376T priority patent/ES2066278T3/es
Priority to AT91110376T priority patent/ATE116312T1/de
Priority to DE69106237T priority patent/DE69106237T2/de
Priority to AU79416/91A priority patent/AU643038B2/en
Priority to PT98115A priority patent/PT98115B/pt
Priority to FI913142A priority patent/FI101224B/fi
Priority to JP3183911A priority patent/JPH04230378A/ja
Priority to IE228091A priority patent/IE66687B1/en
Priority to US07/960,063 priority patent/US5300506A/en
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Priority to SG15595A priority patent/SG15595G/en
Priority to HK51995A priority patent/HK51995A/xx
Publication of SG15595G publication Critical patent/SG15595G/en
Priority to CY183195A priority patent/CY1831A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
SG15595A 1990-06-29 1995-01-30 Antimigraine alkoxypyrimidine derivatives SG15595G (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
CA002043709A CA2043709C (fr) 1990-06-29 1991-05-31 Derives pour combattre la migraine d'alcoxypirimidine
DK91110376.0T DK0464558T3 (da) 1990-06-29 1991-06-24 Antimigræne-alkoxypyrimidinderivater
ES91110376T ES2066278T3 (es) 1990-06-29 1991-06-24 Derivados del alcoxipirimidina contra la migraña.
AT91110376T ATE116312T1 (de) 1990-06-29 1991-06-24 Antimigräne alkoxypyrimidinderivate.
DE69106237T DE69106237T2 (de) 1990-06-29 1991-06-24 Antimigräne Alkoxypyrimidinderivate.
EP91110376A EP0464558B1 (fr) 1990-06-29 1991-06-24 Dérivés antimigraines d'alkoxypyrimidine
PT98115A PT98115B (pt) 1990-06-29 1991-06-27 Processo para a apreparacao de derivados de alcoxipirimidina
AU79416/91A AU643038B2 (en) 1990-06-29 1991-06-27 Antimigraine alkoxypyrimidine derivatives
FI913142A FI101224B (fi) 1990-06-29 1991-06-27 Menetelmä terapeuttisesti käyttökelpoisten alkoksipyrimidiinijohdannai sten valmistamiseksi
JP3183911A JPH04230378A (ja) 1990-06-29 1991-06-28 抗片頭痛アルコキシピリミジン誘導体
IE228091A IE66687B1 (en) 1990-06-29 1991-06-28 Antimigraine alkoxypyrimidine derivatives
US07/960,063 US5300506A (en) 1990-06-29 1992-10-13 Indolylalkyl derivatives of pyrimidinylpiperazine for treating vascular headache
SG15595A SG15595G (en) 1990-06-29 1995-01-30 Antimigraine alkoxypyrimidine derivatives
HK51995A HK51995A (en) 1990-06-29 1995-04-06 Antimigraine alkxypyrimidine derivatives.
CY183195A CY1831A (en) 1990-06-29 1995-12-01 Antimigraine alkoxypyrimidine derivatives

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54612290A 1990-06-29 1990-06-29
US68020891A 1991-04-04 1991-04-04
SG15595A SG15595G (en) 1990-06-29 1995-01-30 Antimigraine alkoxypyrimidine derivatives

Publications (1)

Publication Number Publication Date
SG15595G true SG15595G (en) 1995-06-16

Family

ID=27356028

Family Applications (1)

Application Number Title Priority Date Filing Date
SG15595A SG15595G (en) 1990-06-29 1995-01-30 Antimigraine alkoxypyrimidine derivatives

Country Status (15)

Country Link
US (1) US5300506A (fr)
EP (1) EP0464558B1 (fr)
JP (1) JPH04230378A (fr)
AT (1) ATE116312T1 (fr)
AU (1) AU643038B2 (fr)
CA (1) CA2043709C (fr)
CY (1) CY1831A (fr)
DE (1) DE69106237T2 (fr)
DK (1) DK0464558T3 (fr)
ES (1) ES2066278T3 (fr)
FI (1) FI101224B (fr)
HK (1) HK51995A (fr)
IE (1) IE66687B1 (fr)
PT (1) PT98115B (fr)
SG (1) SG15595G (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077293A (en) * 1990-06-29 1991-12-31 Bristol-Myers Squibb Co. 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines
CA2084531A1 (fr) * 1991-12-19 1993-06-20 David W. Smith Derives antimigraines 4-pyrimidinyle et pyridinyle d'indol-3yl-alkylpiperazines
GB9211277D0 (en) 1992-05-28 1992-07-15 Glaxo Group Inc Pharmaceutical compositions
GB9226610D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
US5521188A (en) * 1993-09-16 1996-05-28 Bristol-Myers Squibb Company Antimigraine cyclobutenedione derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines
CA2130078A1 (fr) * 1993-09-16 1995-03-17 Jonas A. Gylys Derives cyclobutenediones de l'indolylakylpyridinyle et des pyrimidinylpiperazines ayant des proprietes antimigraineuses
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
ES2079323B1 (es) * 1994-06-21 1996-10-16 Vita Invest Sa Derivados de indol utiles para el tratamiento de la migraña, composicion y uso correspondientes.
US5550239A (en) * 1994-11-08 1996-08-27 Bristol-Myers Squibb Company Process for large-scale production of indolyl alkyl pyrimidinyl piperazine compounds
GB9423682D0 (en) * 1994-11-23 1995-01-11 Merck Sharp & Dohme Therapeutic agents
GB9501865D0 (en) * 1995-01-31 1995-03-22 Merck Sharp & Dohme Therapeutic agents
US5618816A (en) * 1995-03-02 1997-04-08 Bristol-Myers Squibb Company Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridnyl and pyrimidinylpiperazines
AU6386196A (en) * 1995-06-19 1997-01-15 Eli Lilly And Company Process for parallel synthesis of a non-peptide library
EP0844996A1 (fr) * 1995-08-07 1998-06-03 MERCK SHARP & DOHME LTD. Derives de 1-indolylpropyl-4-phenethylpiperazine substitues
JPH09124643A (ja) * 1995-08-14 1997-05-13 Bristol Myers Squibb Co 抗うつ作用を有する１−アリールアルキル−４−（アルコキシピリジニル）−又は４−（アルコキシピリミジニル）ピペラジン誘導体
AR004229A1 (es) * 1995-11-06 1998-11-04 Wyeth Corp Derivados indolalquilo de benzodioxanmetilamina y su uso para preparar medicamentos
GB9609374D0 (en) * 1996-05-03 1996-07-10 Merck Sharp & Dohme Therapeutic agents
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
FR2799463B1 (fr) * 1999-10-12 2004-04-16 Adir Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et ces compositions pharmaceutiques qui les contiennent
US20030096379A1 (en) * 2001-03-28 2003-05-22 Kilgore James L. Method for producing tryptamine derivatives
US6800637B2 (en) 2002-09-12 2004-10-05 Wyeth Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines
EP1632491A1 (fr) * 2004-08-30 2006-03-08 Laboratorios Del Dr. Esteve, S.A. composes indole substitues et leur utilisation comme modulateurs du recepteur 5-ht6
JP2009515834A (ja) * 2006-08-29 2009-04-16 テバ ファーマシューティカル インダストリーズ リミティド ５−フェニル−１−トリチル−１ｈ−テトラゾールの合成のための方法
EP2036888A1 (fr) * 2007-09-17 2009-03-18 Laboratorios del Dr. Esteve S.A. Sulfonamides à substitution naphtyl
MX2010009920A (es) * 2008-03-14 2010-09-30 Merck Patent Gmbh Compuestos de azaindol para tratamiento de trastornos del sistema nervioso central.
US20090281114A1 (en) * 2008-05-08 2009-11-12 Fabre-Kramer Pharmaceuticals, Inc. Indolylalkyl derivatives of pyrimidinylpiperazine and metabolites thereof for treatment of anxiety, depression, and sexual dysfunction
US9598401B2 (en) 2013-07-29 2017-03-21 Sunshine Lake Pharma Co., Ltd. Substituted heteroaryl compounds and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB944443A (fr) * 1959-09-25 1900-01-01
GB1189064A (en) * 1967-05-01 1970-04-22 Sterling Drug Inc Indole Derivatives
NL7103002A (fr) * 1970-03-06 1971-09-08
GR79215B (fr) * 1982-06-07 1984-10-22 Glaxo Group Ltd
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
GB8601959D0 (en) * 1986-01-28 1986-03-05 Glaxo Group Ltd Indole derivatives
US4954502A (en) * 1988-06-10 1990-09-04 Bristol-Myers Squibb Company 1-indolyalkyl-4-(substituted-pyridinyl)piperazines
FR2635104B1 (fr) * 1988-08-03 1992-04-30 Synthelabo Derives d'indolone, leur preparation et leur application en therapeutique
US5077293A (en) * 1990-06-29 1991-12-31 Bristol-Myers Squibb Co. 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines

Also Published As

Publication number Publication date
DE69106237D1 (de) 1995-02-09
PT98115A (pt) 1992-03-31
HK51995A (en) 1995-04-13
FI101224B1 (fi) 1998-05-15
AU7941691A (en) 1992-01-02
CA2043709C (fr) 2002-01-22
PT98115B (pt) 1998-12-31
IE66687B1 (en) 1996-01-24
EP0464558A1 (fr) 1992-01-08
FI913142A (fi) 1991-12-30
IE912280A1 (en) 1992-01-01
EP0464558B1 (fr) 1994-12-28
ATE116312T1 (de) 1995-01-15
DE69106237T2 (de) 1995-05-11
FI913142A0 (fi) 1991-06-27
JPH04230378A (ja) 1992-08-19
DK0464558T3 (da) 1995-03-13
CA2043709A1 (fr) 1991-12-30
US5300506A (en) 1994-04-05
AU643038B2 (en) 1993-11-04
CY1831A (en) 1995-12-01
FI101224B (fi) 1998-05-15
ES2066278T3 (es) 1995-03-01

Similar Documents

Publication Publication Date Title
SG15595G (en) Antimigraine alkoxypyrimidine derivatives
MY103352A (en) Piperazinyl-heterocyclic compounds
HU9302384D0 (en) 2,4-diamino-quinazoline derivatives and medical preparatives containing them
NO990542L (no) K-252a-derivater og anvendelse av K-252a-derivater
DE69231123D1 (de) Konjugaten von Zell-bindender Mittel und Derivaten von CC-1065
PH30988A (en) Antimigraine-4-pyrimidinyl and pyridinyl derivatives of indol-3yl-alkyl piperazines.
EP0276536A3 (en) Use of buspirone for the improvement of short term memory
ZA93958B (en) Piperazine and piperidine derivatives and their use in therapy
EP0278173A3 (en) Use of heterocyclic derivatives in the treatment of depressions
IL98110A0 (en) N-(3-fluoro-2-phosphonylmethoxypropyl)derivatives of purine and pyrimidine heterocyclic bases,their preparation and use
AU3959193A (en) Heterocyclic compounds and their use in the treatment of type II-diabetes
NZ237309A (en) 1-(2-(4-morpholino)ethyl)-3-(arylcarbonyl)-indole derivatives and pharmaceutical compositions
HU9501801D0 (en) Lactame-compounds as pharmaceutical active component
ZA918074B (en) N-(2-alkyl-3-mercaptoglutaryl)-amino-diaza cycloakanone derivatives and their use as collage/nase inhibitors.
DE59107445D1 (de) Kombination von Arbeitsgerät und höhenverstellbare Versorgungseinheit
AU2231692A (en) 4-phenylmethylpiperazine derivatives and their use as antiallergic and antihistaminic agents
MY103210A (en) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds.
HU913989D0 (en) Anti-herpetic castanospermin esthers
HK1005016A1 (en) Use of buspirone in sleep apneas
EP0437026A3 (en) Use of tandospirone in the treatment of depression
AU4787593A (en) Heterocyclic derivatives useful in the treatment of cardiovascular diseases
ATE70181T1 (de) Verwendung von oxochinazolinderivaten bei der behandlung von hyperurikaemie.
HUT46192A (en) Fungicides and bactericides comprising pyrimidine derivatives as active ingredient and process for producing the active ingredient
AU4096689A (en) The use of lactam derivatives in the treatment of addiction
AU4096889A (en) The use of lactam derivatives in the treatment of depression